My watch list  

36 Current news of Evonik


You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
Evonik commercializes biosurfactants


Evonik is commercializing biosurfactants: the specialty chemicals company is now the first in the world to use biotech methods for producing industrial-scale quantities of high- quality surfactants—key components of modern shampoos, shower gels, and household cleansers. The achievement has been ...


image description
Enzymes to become potential competitors for petroleum

Evonik researchers and scientists at Graz University discover biotechnology access to 1-alkenes


Researchers at the specialty chemicals company Evonik Industries, in cooperation with scientists at Graz University, have discovered a biocatalytic access to 1-alkenes such as propene and 1-butene. Such hydrocarbon compounds are considered as key substances for the chemical industry's ...


Evonik acquires share in JeNaCell


Evonik has for the first time acquired shares in a young technology company in Germany via its venture capital arm. The Group invested in JeNaCell GmbH and now holds a minority share in the spin-off of Friedrich Schiller University in Jena. JeNaCell is a specialist for nanocellulose generated ...


Industrial chromatography and reverse osmosis optimize amino acid fermentation process


Using creativity and unconventional ideas, researchers and engineers at Evonik have achieved a significant breakthrough in the biotechnological production of amino acids based on fermentation. They integrated the separating methods of chromatography and reverse osmosis and an online analytical ...


Evonik invests in the biotechnology company Algal Scientific


Evonik Industries is investing in the technology startup Algal Scientific Corporation (Northville, Michigan, USA). Evonik is part of an investors’ consortium that is investing more than US$3 million in Series A financing round. Under the trade name AlgamuneTM Algal markets 1,3-β-glucan, a ...


Bacteria like the taste of syngas

A milestone for third-generation biotechnology


For the first time, Evonik Industries has managed to use biotech methods to convert syngas to pure 2-hydroxyisobutyric acid (2-HIBA) under industrial conditions. 2-HIBA is a precursor used in the manufacture of PLEXIGLAS®. Waste gas is one example of a source of syngas. "We have shown that there ...


Evonik selects OPX Biotechnologies for joint development of bio-based chemicals


OPX Biotechnologies, Inc. (OPXBIO) and Evonik Industries AG announced the two companies have entered into an agreement to jointly develop certain bio-based specialty chemicals. The joint-development agreement signed May 3rd 2013 calls for OPXBIO to use its proprietary EDGE™ (Efficiency Directed ...


Evonik invests heavily in biotech

Patrik Wohlhauser, member of the Executive Board: “In the Health & Nutrition Business Unit alone we hope to see sales of €1 billion by 2020 from products made using biotechnology.”


Evonik Industries plans to continue expanding its commitment to biotechnology. “Biotech opens up interesting opportunities for profitable growth in a range of business areas,” says Patrik Wohlhauser, a member of the Executive Board. “It’s also giving Evonik’s growth strategy a stronger focus on ...


Evonik Industries and BRAIN co-operate


Evonik Industries AG and BRAIN AG co-operate in the field of the development of novelmicroorganisms with unique, selective binding- and adsorption characteristics on selected surfaces. Within the co-operation the partners pursue the joint objective of identifying and developing suitable ...


Evonik joint venture for Biolys production in Russia: Executive Board approves realization


Evonik Industries is moving forward with its plans to produce Biolys®, a source of L-lysine for animal nutrition, in the OOO DonBioTech joint venture in Russia. The Evonik Executive Board has approved the realization of the project, based in Volgodonsk in Russia's Rostov region. The DonBioTech ...


Page 2 From 4
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE